Literature DB >> 24275224

Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study.

Joel D Greenspan1, Gary D Slade, Eric Bair, Ronald Dubner, Roger B Fillingim, Richard Ohrbach, Charles Knott, Luda Diatchenko, Qian Liu, William Maixner.   

Abstract

UNLABELLED: Multiple studies report that individuals with chronic temporomandibular disorder (TMD) have enhanced sensitivity to experimental pain. Additionally, chronic TMD cases show altered autonomic function, including elevated heart rate and reduced heart rate variability. However, causal inferences regarding the association between TMD and pain sensitivity and autonomic function cannot be drawn from these cross-sectional observations. The prospective Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study examines whether measures of pain sensitivity or cardiac autonomic function provide predictive value in TMD incidence. A cohort of 2,737 initially TMD-free participants was followed for up to 5.2 years, during which time 260 developed first-onset TMD. Fourteen of 39 experimental pain measures produced significant hazard ratios, such that greater pain sensitivity was associated with greater TMD incidence. A single autonomic measure-heart rate at rest-was also associated significantly with greater TMD incidence. In contrast, using the same measures of pain sensitivity and cardiac autonomic function, we previously reported a larger group of variables that was significantly associated with chronic TMD in the OPPERA case-control study. Future studies should investigate whether premorbid pain sensitivity or autonomic function more specifically predicts risk of developing chronic TMD than first-onset TMD. PERSPECTIVE: Our previous case-control studies showed that associations with both pain sensitivity and cardiac autonomic function are profound in chronic TMD cases. Here we show that some measures of enhanced pain sensitivity contribute modestly to the risk of developing TMD whereas autonomic dysregulation appears to confer little or no risk for TMD incidence.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Quantitative sensory testing; cardiovascular measures; heat pain; orofacial pain; pressure pain; temporomandibular disorder

Mesh:

Year:  2013        PMID: 24275224      PMCID: PMC3955992          DOI: 10.1016/j.jpain.2013.06.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  21 in total

1.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  William Maixner; Joel D Greenspan; Ronald Dubner; Eric Bair; Flora Mulkey; Vanessa Miller; Charles Knott; Gary D Slade; Richard Ohrbach; Luda Diatchenko; Roger B Fillingim
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

Review 2.  Idiopathic pain disorders--pathways of vulnerability.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Roger B Fillingim; William Maixner
Journal:  Pain       Date:  2006-06-13       Impact factor: 6.961

3.  Analysis of stimulus-evoked pain in patients with myofascial temporomandibular pain disorders.

Authors:  Peter Svensson; Thomas List; Gun Hector
Journal:  Pain       Date:  2001-06       Impact factor: 6.961

4.  Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain.

Authors:  W Maixner; R Fillingim; D Booker; A Sigurdsson
Journal:  Pain       Date:  1995-12       Impact factor: 6.961

5.  Five-year outcomes in TMD: relationship of changes in pain to changes in physical and psychological variables.

Authors:  R Ohrbach; S F Dworkin
Journal:  Pain       Date:  1998-02       Impact factor: 6.961

6.  Evidence for up-regulated central nociceptive processing in patients with masticatory myofascial pain.

Authors:  Eleni Sarlani; Edward G Grace; Mark A Reynolds; Joel D Greenspan
Journal:  J Orofac Pain       Date:  2004

7.  Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study.

Authors:  Gary D Slade; Eric Bair; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Luda Diatchenko; William Maixner; Charles Knott; Richard Ohrbach
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

8.  Study protocol, sample characteristics, and loss to follow-up: the OPPERA prospective cohort study.

Authors:  Eric Bair; Naomi C Brownstein; Richard Ohrbach; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; William Maixner; Shad B Smith; Luda Diatchenko; Yoly Gonzalez; Sharon M Gordon; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Dawn Dampier; Charles Knott; Gary D Slade
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study.

Authors:  Richard Ohrbach; Eric Bair; Roger B Fillingim; Yoly Gonzalez; Sharon M Gordon; Pei-Feng Lim; Margarete Ribeiro-Dasilva; Luda Diatchenko; Ronald Dubner; Joel D Greenspan; Charles Knott; William Maixner; Shad B Smith; Gary D Slade
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Decision tree-based learning to predict patient controlled analgesia consumption and readjustment.

Authors:  Yuh-Jyh Hu; Tien-Hsiung Ku; Rong-Hong Jan; Kuochen Wang; Yu-Chee Tseng; Shu-Fen Yang
Journal:  BMC Med Inform Decis Mak       Date:  2012-11-14       Impact factor: 2.796

View more
  37 in total

1.  Multimodal nociceptive mechanisms underlying chronic pelvic pain.

Authors:  Kevin M Hellman; Insiyyah Y Patanwala; Kristen E Pozolo; Frank F Tu
Journal:  Am J Obstet Gynecol       Date:  2015-08-20       Impact factor: 8.661

2.  Pressure pain thresholds fluctuate with, but do not usefully predict, the clinical course of painful temporomandibular disorder.

Authors:  Gary D Slade; Anne E Sanders; Richard Ohrbach; Roger B Fillingim; Ron Dubner; Richard H Gracely; Eric Bair; William Maixner; Joel D Greenspan
Journal:  Pain       Date:  2014-08-15       Impact factor: 6.961

Review 3.  Genomics of Cardiovascular Measures of Autonomic Tone.

Authors:  Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

Review 4.  Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.

Authors:  Brian Walitt; Marta Ceko; John L Gracely; Richard H Gracely
Journal:  Curr Rheumatol Rev       Date:  2016

5.  Identification of relevant subtypes via preweighted sparse clustering.

Authors:  Sheila Gaynor; Eric Bair
Journal:  Comput Stat Data Anal       Date:  2017-06-23       Impact factor: 1.681

6.  Effectiveness of low-level laser therapy on pain intensity, pressure pain threshold, and SF-MPQ indexes of women with myofascial pain.

Authors:  Laís Valencise Magri; Vinícius Almeida Carvalho; Flávia Cássia Cabral Rodrigues; César Bataglion; Christie Ramos Andrade Leite-Panissi
Journal:  Lasers Med Sci       Date:  2017-01-04       Impact factor: 3.161

Review 7.  Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.

Authors:  G D Slade; R Ohrbach; J D Greenspan; R B Fillingim; E Bair; A E Sanders; R Dubner; L Diatchenko; C B Meloto; S Smith; W Maixner
Journal:  J Dent Res       Date:  2016-06-23       Impact factor: 6.116

8.  Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia.

Authors:  Deepika S Darbari; Kathleen J Vaughan; Katherine Roskom; Cassie Seamon; Lena Diaw; Meghan Quinn; Anna Conrey; Alan N Schechter; Jennifer A Haythornthwaite; Myron A Waclawiw; Gwenyth R Wallen; Inna Belfer; James G Taylor
Journal:  Scand J Pain       Date:  2017-09-30

9.  Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions.

Authors:  Gary D Slade; Roger B Fillingim; Anne E Sanders; Eric Bair; Joel D Greenspan; Richard Ohrbach; Ronald Dubner; Luda Diatchenko; Shad B Smith; Charles Knott; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

10.  Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study.

Authors:  Eric Bair; Richard Ohrbach; Roger B Fillingim; Joel D Greenspan; Ronald Dubner; Luda Diatchenko; Erika Helgeson; Charles Knott; William Maixner; Gary D Slade
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.